Qyuns Therapeutics’ US$31 Million Initial Public Offering

O’Melveny represented China International Capital Corporation Hong Kong Securities Limited as the sole sponsor and overall coordinator in the IPO.Qyuns Therapeutics Co., Ltd. (2509.HK) announced its…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

This content is for Standard 1 Year members only.
Login Join Now